KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review
Background The indication for this assessment is the use of the KardiaMobile six-lead electrocardiogram device for the assessment of QT interval-based cardiac risk in service users prior to the initiation of, or for the monitoring of, antipsychotic medications, which are associated with an establish...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2024-03-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/TFHU0078 |